These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33208122)

  • 1. Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster.
    Brandi G; Rizzo A; Deserti M; Relli V; Indio V; Bin S; Pariali M; Palloni A; De Lorenzo S; Tovoli F; Tavolari S
    BMC Med Genet; 2020 Nov; 21(1):225. PubMed ID: 33208122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer.
    Hoblinger A; Grunhage F; Sauerbruch T; Lammert F
    Digestion; 2009; 80(1):36-9. PubMed ID: 19451719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis.
    Qian L; Fang S; Yan YL; Zeng SS; Xu ZJ; Gong ZC
    J Clin Neurosci; 2017 Mar; 37():6-14. PubMed ID: 27816260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.
    Niemi M; Arnold KA; Backman JT; Pasanen MK; Gödtel-Armbrust U; Wojnowski L; Zanger UM; Neuvonen PJ; Eichelbaum M; Kivistö KT; Lang T
    Pharmacogenet Genomics; 2006 Nov; 16(11):801-8. PubMed ID: 17047488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.
    Nguyen TD; Markova S; Liu W; Gow JM; Baldwin RM; Habashian M; Relling MV; Ratain MJ; Kroetz DL
    Pharmacogenomics J; 2013 Oct; 13(5):396-402. PubMed ID: 22664480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.
    Genvigir FDV; Nishikawa AM; Felipe CR; Tedesco-Silva H; Oliveira N; Salazar ABC; Medina-Pestana JO; Doi SQ; Hirata MH; Hirata RDC
    Pharmacotherapy; 2017 May; 37(5):535-545. PubMed ID: 28316087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants may play an important role in mRNA-miRNA interaction: evidence for haplotype-dependent downregulation of ABCC2 (MRP2) by miRNA-379.
    Werk AN; Bruckmueller H; Haenisch S; Cascorbi I
    Pharmacogenet Genomics; 2014 Jun; 24(6):283-91. PubMed ID: 24743544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.
    Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I
    Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
    Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
    Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population.
    Sai K; Saito Y; Itoda M; Fukushima-Uesaka H; Nishimaki-Mogami T; Ozawa S; Maekawa K; Kurose K; Kaniwa N; Kawamoto M; Kamatani N; Shirao K; Hamaguchi T; Yamamoto N; Kunitoh H; Ohe Y; Yamada Y; Tamura T; Yoshida T; Minami H; Matsumura Y; Ohtsu A; Saijo N; Sawada J
    Drug Metab Pharmacokinet; 2008; 23(2):139-47. PubMed ID: 18445995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
    Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
    Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol.
    Haenisch S; May K; Wegner D; Caliebe A; Cascorbi I; Siegmund W
    Pharmacogenet Genomics; 2008 Apr; 18(4):357-65. PubMed ID: 18334920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.
    Ulzurrun E; Stephens C; Ruiz-Cabello F; Robles-Diaz M; Saenz-López P; Hallal H; Soriano G; Roman E; Fernandez MC; Lucena MI; Andrade RJ
    PLoS One; 2014; 9(4):e94675. PubMed ID: 24732756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs.
    Grover S; Gourie-Devi M; Bala K; Sharma S; Kukreti R
    Pharmacogenet Genomics; 2012 Jun; 22(6):447-65. PubMed ID: 22565165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diffuse cholangiocarcinoma in the context of multilobular liver cirrhosis as a manifestation of Wilson-Konovalov disease].
    Ponomarev AB; Kosminkova EN; Generalova SIu
    Arkh Patol; 1994; 56(6):74-7. PubMed ID: 7605225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.
    Haenisch S; Zimmermann U; Dazert E; Wruck CJ; Dazert P; Siegmund W; Kroemer HK; Warzok RW; Cascorbi I
    Pharmacogenomics J; 2007 Feb; 7(1):56-65. PubMed ID: 16788565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of multi-drug resistance-related genes MDR3 and MRP as prognostic factors in clinical liver cancer patients.
    Yu Z; Peng S; Hong-Ming P; Kai-Feng W
    Hepatogastroenterology; 2012; 59(117):1556-9. PubMed ID: 22366465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of new haplotype for ABCC2 gene: rs17222723 and rs8187718 in cis.
    Pratt VM; Beyer BN; Koller DL; Skaar TC; Flockhart DA; Levy KD; Vance GH
    J Mol Diagn; 2015 Mar; 17(2):201-5. PubMed ID: 25554586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI).
    Fujita K; Nagashima F; Yamamoto W; Endo H; Sunakawa Y; Yamashita K; Ishida H; Mizuno K; Matsunaga M; Araki K; Tanaka R; Ichikawa W; Miya T; Narabayashi M; Akiyama Y; Kawara K; Ando Y; Sasaki Y
    Biol Pharm Bull; 2008 Nov; 31(11):2137-42. PubMed ID: 18981587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metallothionein-1 genetic polymorphism and cigarette smoking on the development of hepatocellular carcinoma.
    Wong RH; Huang CH; Yeh CB; Lee HS; Chien MH; Yang SF
    Ann Surg Oncol; 2013 Jun; 20(6):2088-95. PubMed ID: 22805858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.